isomethyleugenol has been researched along with Acute Myelogenous Leukemia in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (12.38) | 18.7374 |
1990's | 14 (13.33) | 18.2507 |
2000's | 8 (7.62) | 29.6817 |
2010's | 40 (38.10) | 24.3611 |
2020's | 30 (28.57) | 2.80 |
Authors | Studies |
---|---|
Gonskikh, Y; Liu, KF; Shen, H; Stoute, J | 1 |
Göllner, S; Kienhöfer, M; Müller-Tidow, C; Pauli, C | 1 |
Fu, HY; Shen, JZ; Zhang, F; Zhou, HR | 1 |
Chen, Q; Lin, J; Qian, J; Shi, J; Yuan, Q; Zhang, L; Zhang, T; Zhang, W; Zhou, H; Zhou, J | 1 |
Du, A; Gao, Y; Jiang, B; Wang, J; Wu, X; Zhang, P; Zhao, Q | 1 |
Fang, K; Han, S; Han, Y; Qi, J; Tang, Y; Wang, H; Wu, D | 1 |
Fu, Y; Huang, L; Huang, M; Liu, H; Shen, D; You, Y; Zhao, B; Zheng, Y | 1 |
Gong, Y; Ouyang, X | 1 |
Bai, X; Chen, X; Li, J; Li, Z; Wang, M; Wu, H; Wu, Y | 1 |
Ali, AM; Salih, GF | 1 |
Aroua, N; Baldus, C; Beckmann, R; Bornhäuser, M; Cheng, J; Fijalkowska, D; Frye, M; Göllner, S; Jeremias, I; Krijgsveld, J; Liu, Y; Lotze, M; Müller-Tidow, C; Oellerich, T; Pabst, C; Raffel, S; Rohde, C; Röllig, C; Sauer, T; Serve, H; Thiede, C; Trumpp, A; Wirth, AK; Yu, X; Yun, H; Zhou, F | 1 |
Cai, X; Chen, M; Chen, S; Lu, X; Qin, W; Zeng, Z | 1 |
Fang, ZH; Feng, WY; Zheng, SY | 1 |
Bray, MR; Chan, KC; Chan, NN; Dang, CC; Dou, Z; Goyama, S; Huen, MS; Kwok, TH; Lam, W; Leung, AY; Leung, WY; Mak, TW; Man, CH; Ng, KL; Ng, TC; So, CWE; Wong, CC; Zeng, XY; Zheng, LC | 1 |
Cai, M; Chen, Y; Hong, Y; Li, S; Liu, Y; Wu, X | 1 |
Palm-Apergi, C | 1 |
Gritsman, K | 1 |
Audebert, S; Bertucci, F; Birnbaum, D; Calmels, B; Camoin, L; Chabannon, C; Chevalier, C; Duprez, E; Finetti, P; Garciaz, S; N'guyen Dasi, L; Platet, N; Pophillat, M; Poplineau, M; Récher, C; Vernerey, J; Vey, N | 1 |
Gorshkov, V; Grinev, V; Helin, K; Hendrickson, RC; Jensen, ON; Kovalchuk, S; Lorenzini, E; Radzisheuskaya, A; Shliaha, PV; Shlyueva, D | 1 |
Al-Kali, A; Bode, AM; Chen, C; Chi, YI; Dou, L; Gao, L; Gao, Y; Huang, H; Li, D; Li, Y; Litzow, MR; Liu, C; Liu, D; Liu, S; Liu, T; Marcucci, G; Pang, J; Shen, N; Shi, J; Singh, P; Wang, L; Wang, Q; Xu, Y; Yan, F; Yu, L; Zheng, D; Zhou, L | 1 |
Baran, Y; Çekdemir, D; Engür, S; Hastar, N; Kiraz, Y; Koca, D; Ulu, GT | 1 |
Kishtagari, A; Levine, RL; Viny, AD | 1 |
An, J; Ko, M | 1 |
Chen, TQ; Chen, YQ; Fang, K; Han, C; Huang, W; Luo, XQ; Pan, Q; Sun, LY; Sun, YM; Wang, D; Wang, WT; Yang, QQ; Zeng, ZC | 1 |
Armstrong, SA; Olsen, SN | 1 |
Asou, N; Benoukraf, T; Matsumura, T; Matsuoka, M; Muddineni, SSNA; Nakamura-Ishizu, A; Okuda, T; Osato, M; Sian, S; Suda, T; Tan, DQ; Tirado-Magallanes, R; Tokunaga, K; Wang, CQ | 1 |
Bernt, KM; Bollig, MK; Chen, BR; Deshpande, AJ; Intlekofer, AM; Kingsley, MC; Libbrecht, C; Pastuer, T; Riedel, SS; Shank, T; Stabler, SP; Xie, HM | 1 |
Chen, Y; Cheng, T; Cheng, X; Chu, Y; Guan, J; Guo, H; Li, M; Shi, D; Shi, J; Wang, B; Wang, X; Xue, C; Yuan, W | 1 |
Hu, H; Muntean, AG; Peterson, LF; Ropa, J; Saha, N; Talpaz, M | 1 |
Aspris, D; Tzelepis, K; Yankova, E | 1 |
Chen, J; Qing, Y; Su, R | 1 |
Barbosa, K; Bohlander, SK; Cox, KL; Deshpande, A; Deshpande, AJ; Khanal, S; Klein, BJ; Kutateladze, TG; Poirier, MG; Shi, X; Sinha, A; Tong, Q; Wen, H; Xuan, F; Zandian, M; Zhang, P; Zhang, Y | 1 |
Kranc, KR | 1 |
Chen, HB; Long, GF; Sun, H; Xu, JR; Yang, DH | 1 |
Bai, J; Chen, H; He, A; Wang, X | 1 |
Dirks, WG; Drexler, HG; Hu, Z; Macleod, RAF; Nagel, S; Pommerenke, C; Quentmeier, H; Wang, Z; Xu, X | 1 |
Bhamra, A; Gil, V; Kwok, C; Petrie, K; Sbirkov, Y; Thompson, AJ; Zelent, A | 1 |
Alvarado, Y; Boddu, P; Borthakur, G; Bose, P; Brandt, M; Cortes, J; Daver, N; DiNardo, CD; Garcia-Manero, G; Jabbour, EJ; Jorgensen, J; Kadia, T; Kantarjian, H; Konopleva, M; Naqvi, K; Pemmaraju, N; Pierce, S; Ravandi, F; Yilmaz, M | 1 |
He, Z; Hu, Y; Huang, P; Li, Y; Liu, J; Liu, P; Lu, W; Wang, J; Wen, S | 1 |
Alberich-Jorda, M; Fiser, K; Kramarzova, KS; Musilova, A; Rejlova, K; Starkova, J; Trka, J; Zaliova, M | 1 |
Fujino, T; Goyama, S; Horikawa, S; Imoto, S; Inaba, T; Inoue, D; Kanai, A; Kawabata, KC; Kitamura, T; Kozuka-Hata, H; Li, Z; Matsui, H; Miyano, S; Nagase, R; Oyama, M; Saika, M; Sheridan, P; Xu, M; Yamaguchi, R; Yang, FC; Yokoyama, A; Zhang, YZ | 1 |
Alachkar, H; Beckford, J; Du, Y; Wu, S | 1 |
Fatica, A; Ianniello, Z | 1 |
Chen, Q; Chen, S; Chen, Z; Li, J; Mi, JQ; Pandolfi, PP; Sun, H; Weng, X; Xu, J; Yan, X; Zhang, W; Zhao, C; Zhao, J; Zhu, J; Zhu, Y | 1 |
Armstrong, SA; Cai, S; Dou, Y; Dressler, GR; Ge, K; Hess, JL; Jang, Y; Koche, R; Levine, RL; Mao, F; Miao, H; Phuc Khoa, LT; Sun, Y; Witkin, M; Xu, J; Zhou, B; Zou, Z | 1 |
Cheng, Y; Kharas, MG; Vu, LP | 1 |
Jamieson, C; Van Der Werf, I | 1 |
Chen, J; Deng, Q; Dong, L; Dong, Z; Gan, J; Gao, Z; Han, L; Huang, Y; Jiang, H; Li, C; Lian, F; Mulloy, JC; Ni, T; Pan, G; Qian, Z; Sheng, Y; Su, R; Wang, Y; Wei, J; Wunderlich, M; Xu, H; Yang, CG; Zhang, N; Zhang, T; Zhang, ZS; Zhong, D; Zhou, H; Zhu, Z | 1 |
Chou, WC; Hou, HA; Hsiao, M; Kuo, YY; Lee, MC; Tien, HF | 1 |
Buchi, F; Gozzini, A; Masala, E; Rossi, A; Sanna, A; Santini, V; Spinelli, E; Valencia, A | 1 |
Campbell, CA; Copeland, RA; Daigle, SR; Iwanowicz, D; Johnston, D; Klaus, CR; Moyer, MP; Olhava, EJ; Pollock, RM; Raimondi, A; Scott, MP; Smith, JJ | 1 |
Armstrong, SA; Banka, D; Bernt, KM; Bradner, JE; Chang, J; Chen, CW; Chen, L; Cihan, A; Deshpande, A; Deshpande, AJ; Dias, S; Dzhekieva, L; Fazio, M; Ibáñez, G; Koche, R; Krivtsov, A; Luo, M; Roeder, RG; Sinha, AU; Zhu, N | 1 |
Gao, L; Kang, HY; Li, MY; Wang, CB; Wang, LL; Wang, W; Wang, XR; Yu, L | 1 |
Gu, H; Jia, X; Lee, KA; Levy, T; Ren, JM; Rikova, K; Silva, JC; Stokes, MP; Yang, V | 1 |
Chen, XP; Jing, Y; Li, YH; Yu, L | 1 |
Levine, RL; Pastore, F | 1 |
Ahn, EY; Baddoo, MC; Butler, TW; Flemington, EK; Huang, G; Kim, JH; Lim, ST; Myers, RM; Park, EY; Park, H; Pauli-Behn, F; Stone, JK; Tan, M; Yan, X | 1 |
Agger, K; Helin, K; Johansen, JV; Kooistra, SM; Miyagi, S; Pedersen, MT | 1 |
Andreeff, M; Campbell, CT; Chevassut, T; Daigle, SR; Deng, L; Goodell, MA; Jeong, M; Kornblau, SM; Li, W; Luo, M; Rau, RE; Rodriguez, BA; Rogers, JH; Rosen, A; Song, Y; Sweet, S | 1 |
Dietrich, D; Dietrich, J; Gevensleben, H; Goltz, D; Grünen, S; Kristiansen, G; Landsberg, J | 1 |
Butler, JS; Coombes, KR; Dent, SY; Kornblau, SM; Qiu, YH; Yoo, SY; Zhang, N | 1 |
Araujo-Cruz, MM; Bakkali, A; Bauser, M; Bochtler, T; Chaturvedi, A; Gabdoulline, R; Ganser, A; Geffers, R; Goparaju, R; Haegebarth, A; Herbst, L; Hess-Stumpp, H; Heuser, M; Ho, AD; Kaulfuss, S; Klett, L; Krämer, A; Neuhaus, R; Panknin, O; Pusch, S; Rehwinkel, H; Rippe, K; Sharma, A; Stichel, D; Struys, EA; Thol, F; Toschi, L; von Deimling, A; Zimmermann, K | 1 |
Galm, O; Herman, JG; Jost, E; Osieka, R; Schmid, J; Schubert, C; Suzuki, H; Wilop, S | 1 |
Cheung, N; So, CW; Yeung, J; Zeisig, BB | 1 |
Armstrong, SA; Bracken, AP; Faber, J; Feng, Z; Jesneck, J; Krivtsov, AV; Kung, AL; Kutok, JL; Lemieux, ME; Silverman, LB; Sinha, AU; Vempati, S; Xia, X | 1 |
Armstrong, SA; Feng, Z; Krivtsov, AV | 1 |
Issa, JP; Oki, Y | 1 |
Agrawal-Singh, S; Becker, A; Berdel, WE; Disselhoff, C; Dugas, M; Ehninger, G; Hascher, A; Isken, F; Klein, HU; Koschmieder, S; McClelland, M; Müller, FU; Müller-Tidow, C; Schlenke, P; Schmitz, W; Seidl, M; Serve, H; Thiede, C; Thoennissen, N; Tickenbrock, L; Tschanter, P; Wang, Y; zur Stadt, U | 1 |
Baran, J; Bukowska-Straková, K; Papiez, MA; Wiczkowski, W | 1 |
Chim, CS; Chung, LP; Jin, DY; Lam, WW; Li, GK; Liang, R; Loong, F; So, CC; Wong, KY | 1 |
Campana, D; Cao, X; Crews, KR; Dolan, ME; Downing, J; Feldberg, T; Gandhi, V; Ghodke, Y; Hartford, C; Lamba, JK; Mitra, AK; Plunkett, W; Pounds, S; Raimondi, S; Ribeiro, RC; Rubnitz, JE | 1 |
Altman, JK; Khan, I; Licht, JD | 1 |
Abdel-Wahab, O; Adli, M; Aifantis, I; Bernstein, BE; Carroll, M; Chung, YR; Gao, J; Hricik, T; Jaffe, JD; Koche, R; LaFave, LM; Levine, RL; Melnick, A; Nimer, SD; Pandey, S; Park, CY; Patel, JP; Perna, F; Shih, AH; Taylor, JE; Zhao, X | 1 |
Akria, L; Arad, A; Aviv, A; Braester, A; Dally, N; Filanovsky, K; Gafter-Gvili, A; Gatt, ME; Hellmann, I; Herishanu, Y; Herzog-Tzarfati, K; Leiba, R; Merkel, D; Mittelman, M; Nagler, A; Nemets, A; Ofran, Y; Ronson, A; Rouvio, O; Silbershatz, I; Tadmor, T; Vidal, L; Yeganeh, S | 1 |
Di Mario, A; Guidi, F; Hohaus, S; Leone, G; Pagano, L; Scardocci, A; Voso, MT; Zini, G | 1 |
Balkhi, MY; Behre, G; Behre, HM; Bohlander, SK; Christopeit, M; Geletu, M; Trivedi, AK | 1 |
Baumann, H; Ghoshal Gupta, S; Wetzler, M | 1 |
Christman, JK; Herzog, D; Mendelsohn, N; Schneiderman, N | 1 |
Bouchard, J; Momparler, RL; Onetto, N; Rivard, GE | 1 |
Kersten, W; Mach, M; Schneider, U | 1 |
Hoffman, DR; Huberman, E | 1 |
Cassileth, PA; Cooper, RA; Suholet, D | 1 |
Dhodapkar, M; Grill, J; Lust, JA | 1 |
Bradstock, KF; Kennedy, BG; Sewell, WA; Tschuchnigg, M | 1 |
Holmes, EH; Hu, J; Macher, BA; Stults, CL | 1 |
Kawakubo, K; Kimura, N; Nakazawa, S; Ohyashiki, JH; Ohyashiki, K; Tauchi, T; Toyama, K | 2 |
Bessho, M; Boyd, Y; Hirashima, K; Jinnai, I; Murohashi, I; Nagai, K; Tomonaga, M; Toyoda, A; Yoshida, S | 1 |
Breit, TM; van Dongen, JJ; Wolvers-Tettero, IL | 1 |
Baylin, SB; Herman, JG; Jen, J; Merlo, A | 1 |
Chim, CS; Kwong, YL; Liang, R; Tam, CY | 1 |
Buckley, JD | 1 |
Ganser, A; Herrmann, F; Lübbert, M; Ludwig, WD; Mertelsmann, R; Oster, W | 1 |
Gale, RE; Linch, DC; Wheadon, H | 1 |
Alhonen, L; Hämäläinen, E; Heinonen, K; Hiltunen, H; Jänne, J; Wahlfors, J | 1 |
Baylin, SB; Benson, J; Evatt, BL; Fukuhara, T; Hooper, WC; Olson, AC; Pruckler, J; Vogler, WR | 1 |
Brunning, RD; Goldfarb, AN; Litz, CE; Strickler, JG | 1 |
Bouchard, J; Momparler, RL; Samson, J | 1 |
Cheng, YC; Degraw, JI; Dutschman, GE; Nair, MG; Sirotnak, FM; Ueda, T | 1 |
Boggs, BA; Chinault, AC; McCredie, KB; Spitzer, G; Stass, SA; Yoffe, G | 1 |
Wong, T; Wu, MC; Yunis, AA; Ziboh, VA | 1 |
Cohen, MB; Glazer, RI; Hartman, KD; Knode, MC; Linevsky, J | 1 |
Grosso, LE; Pitot, HC | 1 |
Andreoli, A; Mauri, C; Torelli, GM; Torelli, UL | 1 |
Griffin, AC; Saunders, GF; Shirakawa, S | 1 |
14 review(s) available for isomethyleugenol and Acute Myelogenous Leukemia
Article | Year |
---|---|
Epitranscriptomic modifications in acute myeloid leukemia: m
Topics: Core Binding Factor Alpha 2 Subunit; Humans; Leukemia, Myeloid, Acute; Methylation | 2021 |
Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; RNA; RNA, Messenger | 2022 |
One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
Topics: Adenosine; Humans; Leukemia, Myeloid, Acute; Methylation; RNA; Stem Cells; Tumor Microenvironment | 2022 |
[Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review].
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Leukemia, Myeloid, Acute; Methylation; Prognosis | 2023 |
Driver mutations in acute myeloid leukemia.
Topics: Epigenomics; Humans; Leukemia, Myeloid, Acute; Methylation; Mutation; Transcription Factors | 2020 |
The N6-methyladenosine RNA modification in acute myeloid leukemia.
Topics: Adenosine; Animals; Biomarkers; Disease Management; Disease Susceptibility; Epigenesis, Genetic; Epigenomics; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Methylation; RNA | 2021 |
RNA modifications in hematopoietic malignancies: a new research frontier.
Topics: Adenosine; Hematologic Neoplasms; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Methylation; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2021 |
MicroRNA: an important regulator in acute myeloid leukemia.
Topics: Animals; Cell Transformation, Neoplastic; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Methylation; MicroRNAs; RNA Processing, Post-Transcriptional | 2017 |
N6-Methyladenosine Role in Acute Myeloid Leukaemia.
Topics: Adenosine; DNA; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Methylation; RNA Processing, Post-Transcriptional; RNA, Messenger | 2018 |
The Biology of m
Topics: Animals; Cell Differentiation; Gene Expression Regulation, Neoplastic; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Methylation; RNA, Messenger | 2019 |
[Markers for Predicting Response to Hypomethylating Agents in MDS and AML Patients].
Topics: Biomarkers, Tumor; Bone Marrow; Humans; Leukemia, Myeloid, Acute; Methylation; Myelodysplastic Syndromes | 2015 |
Epigenetic regulators and their impact on therapy in acute myeloid leukemia.
Topics: Acetylation; Antimetabolites, Antineoplastic; Clinical Trials as Topic; DNA, Neoplasm; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Molecular Targeted Therapy; Neoplasm Proteins; Signal Transduction | 2016 |
Epigenetic mechanisms in AML - a target for therapy.
Topics: Acetylation; Antimetabolites, Antineoplastic; Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Delivery Systems; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Neoplasm Proteins; Protein Processing, Post-Translational | 2010 |
Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.
Topics: Epigenesis, Genetic; Humans; Leukemia, Myeloid, Acute; Methylation; Signal Transduction; STAT3 Transcription Factor | 2008 |
91 other study(ies) available for isomethyleugenol and Acute Myelogenous Leukemia
Article | Year |
---|---|
Human DIMT1 generates N
Topics: Amino Acid Substitution; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Mutation, Missense; Neoplasm Proteins; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2021 |
Genistein-induced Anticancer Effects on Acute Leukemia Cells Involve the Regulation of Wnt Signaling Pathway Through H4K20me1 Rather Than DNA Demethylation.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Demethylation; Gene Expression Regulation, Neoplastic; Genistein; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Phosphorylation; Sequence Analysis, DNA; Up-Regulation; Wnt Signaling Pathway | 2021 |
Expression characteristic of
Topics: Adolescent; Adult; B7 Antigens; Case-Control Studies; Cell Line, Tumor; Gene Expression Regulation, Leukemic; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Membrane Proteins; Methylation; Middle Aged; Multivariate Analysis; Protein Isoforms; RNA, Messenger; ROC Curve; Treatment Outcome; Young Adult | 2021 |
m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
Topics: Adenosine; B7-H1 Antigen; Biomarkers, Tumor; Case-Control Studies; Databases, Genetic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Methylation; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Mutation; Programmed Cell Death 1 Ligand 2 Protein; RNA Processing, Post-Transcriptional; RNA, Neoplasm; Signal Transduction; Tumor Microenvironment | 2021 |
Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia.
Topics: Epigenesis, Genetic; Humans; Leukemia, Myeloid, Acute; Methylation; Prognosis; Tumor Microenvironment | 2022 |
MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Ki-67 Antigen; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Mice; MicroRNAs | 2022 |
Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia.
Topics: DNA Methylation; DNA Methyltransferase 3A; DNA Modification Methylases; Humans; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Mutation; Neoplasm Recurrence, Local | 2022 |
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia.
Topics: Animals; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Neoplastic Stem Cells; Phenotype; Ribosomes; RNA, Ribosomal | 2023 |
A novel prognostic model of methylation-associated genes in acute myeloid leukemia.
Topics: Databases, Factual; Humans; Leukemia, Myeloid, Acute; Methylation; Multivariate Analysis; Prognosis | 2023 |
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML.
Topics: Animals; Histones; Immunity; Leukemia, Myeloid, Acute; Methylation; Mice; Mutation; Nucleotidyltransferases; Polyploidy; Tumor Suppressor Protein p53 | 2023 |
m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia.
Topics: 5-Methylcytosine; Humans; Immunotherapy; Leukemia, Myeloid, Acute; Methylation; Prognosis; Tumor Microenvironment | 2023 |
PLK4, a potential target against AML.
Topics: Histones; Humans; Immunity; Leukemia, Myeloid, Acute; Methylation; Nucleotidyltransferases; Protein Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2023 |
FLT3-ITD gets by with a little help from PRMT1.
Topics: Arginine; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Mutation; Protein-Arginine N-Methyltransferases; Repressor Proteins | 2019 |
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.
Topics: Adult; Aged; Cell Differentiation; Cell Line, Tumor; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Genetic Loci; Histones; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Prognosis; Survival Analysis; Young Adult | 2019 |
PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Arginine; Catalysis; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Molecular Targeted Therapy; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Oncogene Proteins, Fusion; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Proteomics; RNA Splicing; Serine-Arginine Splicing Factors | 2019 |
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Core Binding Factor Alpha 2 Subunit; Gene Knockdown Techniques; Humans; Jurkat Cells; Leukemia, Myeloid, Acute; Methylation; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Oncogene Proteins, Fusion; Polycomb Repressive Complex 2; Prognosis; RNA, Messenger; RUNX1 Translocation Partner 1 Protein; THP-1 Cells | 2019 |
Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Caspase 3; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Methylation; Molecular Targeted Therapy; Protein Interaction Domains and Motifs | 2020 |
Decoding ribosomes to keep growing (in AML).
Topics: Cell Proliferation; Humans; Leukemia, Myeloid, Acute; Methylation; Protein Biosynthesis; Ribosomes; RNA, Ribosomal, 18S | 2020 |
The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
Topics: Animals; Cell Self Renewal; Child, Preschool; Female; Gene Expression Regulation, Leukemic; Genetic Vectors; Heterografts; Histone-Lysine N-Methyltransferase; Histones; Homeodomain Proteins; Humans; Infant; Leukemia, Myeloid, Acute; Lysine; Lysosomal Membrane Proteins; Male; Methylation; Mice; Mice, Inbred NOD; Mice, SCID; Myeloid-Lymphoid Leukemia Protein; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; Protein Processing, Post-Translational; Recombinant Fusion Proteins; RNA Interference; RNA, Antisense; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Specific Pathogen-Free Organisms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2020 |
It's Not What You Say But How You Say It: Targeting RNA Methylation in AML.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Immune Evasion; Leukemia, Myeloid, Acute; Methylation; Neoplastic Stem Cells; RNA | 2020 |
Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Topics: Animals; Apoptosis; Cell Survival; Core Binding Factor Alpha 2 Subunit; Family; Female; Genetic Predisposition to Disease; Genotype; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Methylation; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Mutation, Missense; Myelodysplastic Syndromes; Pedigree; Protein Processing, Post-Translational | 2020 |
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML.
Topics: Gene Rearrangement; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Oncogenes | 2020 |
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Hematopoietic Stem Cells; Histones; Humans; Leukemia, Myeloid, Acute; Lysine; Methylation; Methyltransferases; Mice; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Repressor Proteins; Transcription, Genetic | 2020 |
SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
Topics: Animals; Histone-Lysine N-Methyltransferase; Histones; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Lysine; Methylation; Mice; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion | 2020 |
The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Topics: Acute Disease; Animals; Carcinogenesis; Cell Transformation, Neoplastic; Chromatin; HEK293 Cells; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Models, Molecular; Monomeric Clathrin Assembly Proteins; Nucleosomes; Protein Conformation; Transcription Factors; Translocation, Genetic | 2021 |
The essential reading list for AML: the m6A transcripts.
Topics: Humans; Leukemia, Myeloid, Acute; Methylation; Reading; RNA, Messenger | 2021 |
[Establishment and validation of prognosis predictive model using m
Topics: Child; Cohort Studies; Humans; Leukemia, Myeloid, Acute; Methylation; RNA; RNA Helicases | 2021 |
KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.
Topics: Cell Line, Tumor; Gene Expression Regulation, Leukemic; Histones; Homeodomain Proteins; Humans; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Methylation; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Response Elements; Transcription Factors; Translocation, Genetic; Tretinoin | 2018 |
Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.
Topics: Amino Acid Sequence; Carrier Proteins; Cell Line, Tumor; Computational Biology; Enhancer of Zeste Homolog 2 Protein; Gene Ontology; Histones; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mass Spectrometry; Methylation; Models, Molecular; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Interaction Maps; Workflow | 2017 |
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Recurrence; Risk | 2018 |
Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Synergism; Energy Metabolism; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Epigenesis, Genetic; Female; Histone Demethylases; Histones; HL-60 Cells; Humans; Hydrazines; Leukemia, Myeloid, Acute; Methylation; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Morpholines; Proto-Oncogene Proteins c-bcl-2; Pyridones; Sulfonamides; Time Factors; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays | 2018 |
Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Topics: Benzazepines; Cell Differentiation; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Genes, Homeobox; Histone Demethylases; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Methylation; Nuclear Proteins; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Pyrimidines; Tretinoin | 2018 |
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies.
Topics: Animals; Cell Differentiation; Female; HEK293 Cells; Histones; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Mice, Inbred C57BL; Myelodysplastic Syndromes; N-Acetylglucosaminyltransferases; Protein Stability; Repressor Proteins; Tumor Suppressor Proteins | 2018 |
Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Multivariate Analysis; Mutation; RNA, Messenger; Treatment Outcome; Up-Regulation; Vimentin; Young Adult | 2018 |
Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Gene Expression Profiling; Histone-Lysine N-Methyltransferase; Histones; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Mice, Transgenic; Myeloid Cells; Nuclear Proteins; Nucleophosmin; Protein Processing, Post-Translational; Proto-Oncogene Proteins | 2018 |
HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.
Topics: Animals; Cell Transformation, Neoplastic; Enhancer Elements, Genetic; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Methylation; Promoter Regions, Genetic | 2018 |
The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Leukemia, Myeloid, Acute; Methylation; Oncogenes; RNA; Stem Cells | 2019 |
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Methylation; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Transgenic; Molecular Targeted Therapy; Protein Conformation; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Structure-Activity Relationship; U937 Cells; Xenograft Model Antitumor Assays | 2019 |
Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Topics: Apoptosis; Cell Line, Tumor; DNA-Binding Proteins; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Piperazines; Promoter Regions, Genetic; Protein Binding; Repressor Proteins; RNA Interference; STAT5 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Transcription Factors; Transcription, Genetic; Transcriptional Activation | 2014 |
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3.
Topics: Acetylation; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Survival; Chromatin Assembly and Disassembly; Core Binding Factor Alpha 2 Subunit; Decitabine; DNA Modification Methylases; Gene Silencing; Histones; Humans; Interleukin-3; Leukemia, Myeloid, Acute; Methylation; Promoter Regions, Genetic; Proto-Oncogene Proteins; RUNX1 Translocation Partner 1 Protein; Transcription Factors | 2014 |
DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Growth Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases | 2014 |
AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.
Topics: Adenosine; Animals; Bone Marrow Cells; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Mice; Mice, Transgenic; Molecular Sequence Data; Neoplasms, Experimental; Nuclear Pore Complex Proteins; Nuclear Proteins; Oncogene Proteins, Fusion; Phenylurea Compounds; Transcription Factors | 2014 |
[Clinical Implications on ZO-1 Gene Methylation in Myelodysplastic Syndrome Progression].
Topics: Bone Marrow; Disease Progression; DNA Methylation; Humans; Leukemia, Myeloid, Acute; Methylation; Myelodysplastic Syndromes; Polymerase Chain Reaction; Zonula Occludens-1 Protein | 2015 |
Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion.
Topics: Acetylation; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromatography, Liquid; Female; Humans; Leukemia, Myeloid, Acute; Methylation; Neoplasm Proteins; Protein Processing, Post-Translational; Proteomics; Tandem Mass Spectrometry | 2016 |
SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.
Topics: Alternative Splicing; Cell Line, Tumor; Chromatin; DNA-Binding Proteins; Gene Expression Regulation, Leukemic; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Methylation; Minor Histocompatibility Antigens; Myeloid-Lymphoid Leukemia Protein; Protein Binding; Protein Isoforms; Proto-Oncogene Proteins; Transcription, Genetic | 2016 |
Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Interleukin-3 Receptor alpha Subunit; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Methylation; Mice; Mice, Knockout; Protein Binding; Tamoxifen | 2016 |
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
Topics: Adenosine; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Leukemia, Myeloid, Acute; Lysine; Methylation; Methyltransferases; Mice, Inbred C57BL; Molecular Targeted Therapy; Mutation; Phenylurea Compounds; Rats; Time Factors; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2016 |
PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.
Topics: B7-H1 Antigen; Epigenesis, Genetic; Female; Humans; Immunity, Innate; Inflammation; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Promoter Regions, Genetic; T-Lymphocytes; Up-Regulation | 2017 |
Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Epigenesis, Genetic; Female; fms-Like Tyrosine Kinase 3; Gene Expression; Gene Expression Profiling; Histones; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Prognosis; Protein Processing, Post-Translational; Transcription Factors; Young Adult | 2017 |
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; DNA Methylation; Enzyme Inhibitors; Glutarates; Histone Code; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Methylation; Mice; Molecular Targeted Therapy; Mutation; Mutation, Missense; Myeloid Cells; Myelopoiesis; Neoplasm Proteins; Neoplastic Stem Cells; Point Mutation; Protein Processing, Post-Translational; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2017 |
Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; CpG Islands; Epigenesis, Genetic; Eye Proteins; Female; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Male; Membrane Proteins; Methylation; Middle Aged; Polymerase Chain Reaction; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Wnt Proteins | 2008 |
Reconstructing the disease model and epigenetic networks for MLL-AF4 leukemia.
Topics: Animals; Disease Models, Animal; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
Topics: Animals; Biomarkers, Tumor; Cell Differentiation; Cells, Cultured; Chromatin Immunoprecipitation; Female; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Rearrangement; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Homeodomain Proteins; Humans; Immunophenotyping; Integrases; Leukemia, Myeloid, Acute; Lysine; Male; Methylation; Methyltransferases; Mice; Mice, Transgenic; Myeloid-Lymphoid Leukemia Protein; Oligonucleotide Array Sequence Analysis; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Principal Component Analysis; Protein Methyltransferases; RNA, Small Interfering; Transcription, Genetic | 2008 |
Transformation from committed progenitor to leukemia stem cells.
Topics: Animals; Cell Transformation, Neoplastic; Hematopoietic Stem Cells; Histones; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Myeloid-Lymphoid Leukemia Protein; Neoplastic Stem Cells | 2009 |
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.
Topics: Adolescent; Antigens, CD34; Child; Child, Preschool; Disease-Free Survival; Female; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Histones; Humans; Infant; Leukemia, Myeloid, Acute; Lysine; Male; Methylation; Prognosis; Promoter Regions, Genetic; Protein Binding; Transcription Factors; Tumor Cells, Cultured | 2010 |
Antileukemic action of (-)-epicatechin in the spleen of rats with acute myeloid leukemia.
Topics: Animals; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Catechin; Cell Line; Comet Assay; DNA Damage; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Leukemia, Myeloid, Acute; Methylation; Organ Size; Oxidation-Reduction; Phosphatidylserines; Purines; Rats; Spleen | 2010 |
Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase 6; Epigenesis, Genetic; Female; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylation; MicroRNAs; Middle Aged; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Young Adult | 2011 |
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.
Topics: 5'-Nucleotidase; Antimetabolites, Antineoplastic; Base Sequence; Blotting, Western; Cell Line; Cell Line, Tumor; Child; Cytarabine; Cytosol; DNA; Electrophoretic Mobility Shift Assay; Exons; Genetic Variation; Humans; Leukemia, Myeloid, Acute; Luciferases; Methylation; Molecular Sequence Data; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors | 2011 |
New strategies in acute myeloid leukemia: redefining prognostic markers to guide therapy.
Topics: Apoptosis; Chromosome Aberrations; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Methylation; Mutation; Pathology, Molecular; Prognosis; Signal Transduction | 2012 |
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Hematopoietic System; Histones; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Mutation; Myeloid Cells; Polycomb Repressive Complex 2; Polycomb-Group Proteins; Protein Binding; ras Proteins; Repressor Proteins; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Up-Regulation | 2012 |
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Chromosome Aberrations; Disease Susceptibility; Female; Humans; Incidence; Infections; Israel; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia | 2013 |
Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.
Topics: Aged; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Cells; Calcium-Calmodulin-Dependent Protein Kinases; Cell Transformation, Neoplastic; Death-Associated Protein Kinases; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Polymerase Chain Reaction | 2004 |
Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.
Topics: Cell Shape; Cytogenetics; Female; Gene Regulatory Networks; Humans; Leukemia, Myeloid, Acute; Male; Mass Spectrometry; Methylation; Protein Processing, Post-Translational; Proteome; Proteomics; Risk Factors | 2006 |
Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60).
Topics: Azacitidine; Cell Differentiation; Cell Line; Clone Cells; DNA (Cytosine-5-)-Methyltransferases; DNA, Neoplasm; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Superoxides; Tetradecanoylphorbol Acetate | 1983 |
5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
Topics: Azacitidine; Cell Line; Decitabine; DNA, Neoplasm; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methylation | 1984 |
Excretion of polyamines by children with leukemia during chemotherapy.
Topics: Child; Child, Preschool; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methylation; Neuroblastoma; Polyamines; Putrescine; RNA, Transfer; Spermidine; Vincristine | 1983 |
The control of phospholipid methylation by phorbol diesters in differentiating human myeloid HL-60 leukemia cells.
Topics: Alkaloids; Cell Differentiation; Cell Line; Humans; Leukemia, Myeloid, Acute; Lyngbya Toxins; Methylation; Methyltransferases; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phorbols; Phosphatidylethanolamine N-Methyltransferase; Phospholipids; Tetradecanoylphorbol Acetate | 1982 |
Early changes in phosphatidylcholine metabolism in human acute promyelocytic leukemia cells stimulated to differentiate by phorbol ester.
Topics: Cell Transformation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Methylation; Phorbol Esters; Phorbols; Phosphatidylcholines; Phospholipids; Tetradecanoylphorbol Acetate; Time Factors | 1981 |
Abnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromes.
Topics: Aged; Base Sequence; Blotting, Southern; Calcitonin; Humans; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Molecular Sequence Data; Myelodysplastic Syndromes; Polymerase Chain Reaction; Survival Rate | 1995 |
Molecular analysis of CD2 gene expression in acute myeloblastic leukemia expressing T-lineage associated surface antigens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Surface; Blotting, Northern; Blotting, Southern; CD2 Antigens; Gene Expression Regulation, Leukemic; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Methylation; RNA, Messenger; T-Lymphocytes | 1995 |
Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukaemia cells.
Topics: Carbohydrate Sequence; Cell Differentiation; Galactosyltransferases; Glycosphingolipids; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Methylation; Molecular Sequence Data; N-Acetylglucosaminyltransferases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1994 |
Hypomethylated status, but not RAG-1, is required for T-cell receptor-beta-chain gene rearrangement in acute leukemia cells.
Topics: Acute Disease; Adult; Base Sequence; Burkitt Lymphoma; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Genes, RAG-1; Humans; Leukemia, Myeloid, Acute; Methylation; Molecular Sequence Data | 1994 |
A clonal study of hematopoiesis using the M27 beta probe: aberrant band patterns caused by incomplete digestion of a methyl-sensitive enzyme in the the inactive X-chromosome.
Topics: Blotting, Southern; DNA Probes; DNA Restriction Enzymes; Female; Hematopoiesis; Heterozygote; Humans; Leukemia, Myeloid, Acute; Methylation; Polymorphism, Restriction Fragment Length; Transcriptional Activation; X Chromosome | 1993 |
Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
Topics: Base Sequence; Basic Helix-Loop-Helix Transcription Factors; CD3 Complex; Cells, Cultured; Child; DNA Primers; DNA-Binding Proteins; DNA, Neoplasm; Gene Deletion; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Methylation; Molecular Sequence Data; Oncogene Proteins, Fusion; Phenotype; Proteins; Proto-Oncogene Proteins; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; T-Cell Acute Lymphocytic Leukemia Protein 1; T-Lymphocytes; Transcription Factors; Tumor Cells, Cultured | 1994 |
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Topics: Adult; Breast Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cell Line; Child; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 9; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Dinucleoside Phosphates; DNA; DNA, Neoplasm; Female; Genes, Tumor Suppressor; Glioma; Homozygote; Humans; Leukemia; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphocytes; Male; Methylation; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Reference Values; Restriction Mapping; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1996 |
Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Genes, p16; Humans; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Sensitivity and Specificity; Transcription Factors; Transcriptional Activation; Tumor Suppressor Proteins | 2001 |
The aetiology of cancer in the very young.
Topics: Base Sequence; Carcinoma, Hepatocellular; Case-Control Studies; Child, Preschool; DNA; DNA Replication; Eye Neoplasms; Humans; Incidence; Infant; Kidney Neoplasms; Leukemia, Myeloid, Acute; Liver Neoplasms; Methylation; Models, Genetic; Registries; Retinoblastoma; United States; Wilms Tumor | 1992 |
A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias.
Topics: Blotting, Northern; Blotting, Southern; DNA Probes; DNA, Neoplasm; Gene Expression; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methylation; Peroxidase; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
T-cell receptor beta chain gene rearrangement in acute myeloid leukemia always occurs at the allele that contains the undermethylated J beta 1 region.
Topics: Adolescent; Adult; Aged; Alleles; DNA, Neoplasm; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Granulocytes; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Restriction Mapping | 1992 |
Assessment of X-chromosome inactivation patterns using the hypervariable probe M27 beta in normal hemopoietic cells and acute myeloid leukemic blasts.
Topics: Bone Marrow Cells; DNA Probes; DNA, Neoplasm; Dosage Compensation, Genetic; Female; Hematopoietic Stem Cells; Heterozygote; Humans; Hypoxanthine Phosphoribosyltransferase; Leukemia, Myeloid, Acute; Methylation; Phosphoglycerate Kinase; Polymorphism, Restriction Fragment Length | 1992 |
Genomic hypomethylation in human chronic lymphocytic leukemia.
Topics: Chromatography, High Pressure Liquid; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; DNA, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methylation; Multiple Myeloma; Ornithine Decarboxylase; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Messenger | 1992 |
Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene. A new, sensitive approach to monitor tumor cells in acute myelogenous leukemia.
Topics: Base Sequence; Blotting, Southern; Bone Marrow; Calcitonin; DNA, Neoplasm; Humans; Leukemia, Myeloid, Acute; Methods; Methylation; Molecular Sequence Data; Monitoring, Physiologic; Polymerase Chain Reaction | 1992 |
Presence of cell lineage-specific hypomethylated sites in the major breakpoint cluster region.
Topics: Blotting, Southern; DNA; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocytes; Lymphocytes; Methylation; Nucleic Acid Hybridization; Reference Values; Restriction Mapping | 1990 |
Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine.
Topics: Antineoplastic Agents; Azacitidine; Cell Differentiation; Cell Line; Decitabine; Dimethyl Sulfoxide; DNA; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid, Acute; Methylation; Superoxides | 1985 |
Inhibitory action of 10-deazaaminopterins and their polyglutamates on human thymidylate synthase.
Topics: Alkylation; Aminopterin; Humans; Kinetics; Leukemia, Myeloid, Acute; Methotrexate; Methylation; Peptides; Polyglutamic Acid; Structure-Activity Relationship; Thymidylate Synthase | 1986 |
Determination of clonality in acute nonlymphocytic leukemia by restriction fragment length polymorphism and methylation analysis.
Topics: Acute Disease; Adult; Child, Preschool; Clone Cells; DNA, Neoplasm; Female; Humans; Hypoxanthine Phosphoribosyltransferase; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Polymorphism, Restriction Fragment Length | 1987 |
Induced rapid phospholipid methylation and arachidonic acid release by dimethyl sulfoxide-treated human promyelocytic leukemic HL-60 cells.
Topics: Arachidonic Acid; Arachidonic Acids; Cell Differentiation; Dimethyl Sulfoxide; Humans; Hydrolysis; Leukemia, Myeloid, Acute; Methylation; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids | 1986 |
Effect of neplanocin A on differentiation, nucleic acid methylation, and c-myc mRNA expression in human promyelocytic leukemia cells.
Topics: Adenosine; Antimetabolites, Antineoplastic; Cell Differentiation; Cell Division; Cell Line; DNA, Neoplasm; Gene Expression Regulation; Humans; Leukemia, Myeloid, Acute; Methylation; Oncogenes; RNA, Neoplasm | 1985 |
Chromatin structure of the c-myc gene in HL-60 cells during alterations of transcriptional activity.
Topics: Cell Line; Chromatin; Dimethyl Sulfoxide; DNA; Humans; Leukemia, Myeloid, Acute; Methylation; Oncogenes; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1985 |
Partial failure of methylation and cleavage of 45S RNA in the blast cells of acute leukaemia.
Topics: Acute Disease; Centrifugation, Density Gradient; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukocytes; Methionine; Methylation; RNA; Tritium; Uridine | 1970 |
In vivo methylation of DNA in human leukocytes.
Topics: Adenine; Cytosine; DNA; Guanine; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Methionine; Methylation; Thymine; Tritium | 1971 |